Liver transplantation for hepatocellular carcinoma: The Baylor experience

Journal of Hepato-Biliary-Pancreatic Sciences

Volumn 17, Issue 5, 2010, Pages 559-566

  Onaca, Nicholas ^a   Klintmalm, Goran B ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Hepatocellular carcinoma; Liver transplantation; Outcome; Survival

Indexed keywords

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHEMOEMBOLIZATION; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PROGRESSION FREE SURVIVAL; RECURRENCE RISK; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR ABLATION; TUMOR VOLUME; UNITED STATES; BIOPSY; COMPARATIVE STUDY; FOLLOW UP; HOSPITAL ADMISSION; LIVER TUMOR; LIVING DONOR; MIDDLE AGED; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; STATISTICS; TUMOR RECURRENCE; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; BIOPSY; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREVALENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TEXAS; TREATMENT OUTCOME; WAITING LISTS;

EID: 79952110078     PISSN: 18686974     EISSN: 18686982     Source Type: Journal    
DOI: 10.1007/s00534-009-0163-x     Document Type: Article

References (40)

1. Mor E, Kaspa RT, Sheiner P, Schwartz M. Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med. 1998;129:643-53. (Pubitemid 28480821)
2. Nart D, Arikan C, Akyildiz M, Yuce G, Demirpolat G, Zeytunlu M, et al. Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis. Transplant Proc. 2003;35:2986-90.
3. Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 1998;227:424-32. (Pubitemid 28131024)
4. Ringe B, Pichlmayr R, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991;15:270-85.
5. Weber M, Kadry Z, Clavien PA. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression? Transplantation. 2002;74:1664-5.
6. Fung J, Marsh W. The quandary over liver transplantation for hepatocellular carcinoma: the greater sin? Liver Transpl. 2002;8:775-7.
7. Iwatsuki S, Starzl TE, Yokoyama I, Demetris AJ, Todo S, Tzakis AG, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991;214:221-8.
8. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228:479-90. (Pubitemid 30194392)
9. Marsh JW, Dvorchik I. Liver organ allocation for hepatocellular carcinoma: are we sure? Liver Transpl. 2003;9:693-6.
10. Neuhaus P, Jonas S, Bechstein WO, Wex C, Kling N, Settmacher U, et al. Liver transplantation for hepatocellular carcinoma. Transplant Proc. 1999;31:469-71.
11. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991;110:726-34.
12. Ryder SD. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (HCC) in adults. Gut. 2003;52(Suppl 3):iii1-8.
13. Adam R, McMaster P, O'Grady JG, Castaing D, Klempnauer JL, Jamieson N, et al. Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry. Liver Transpl. 2003;9:1231-43. (Pubitemid 37536793)
14. Llovet JM, Bruix J, Fuster J, Garcia-Valdecasas JC, Grande L, Bru C, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998;27:1572-7. (Pubitemid 28264681)
15. Moya A, Berenguer M, Aguilera V, Juan FS, Nicolas D, Pastor M, et al. Hepatocellular carcinoma: can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C? Liver Transpl. 2002;8:1020-7.
16. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-9. (Pubitemid 26079803)
17. Lauenstein TC, Salman K, Morreira R, Heffron T, Spivey JR, Martinez E, et al. Gadolinium-enhanced MRI for tumor surveillance before liver transplantation: center-based experience. AJR Am J Roentgenol. 2007;189:663-70. (Pubitemid 47328550)
18. Zhao H, Yao JL, Wang Y, Zhou KR. Detection of small hepatocellular carcinoma: comparison of dynamic enhancement magnetic resonance imaging and multiphase multirow-detector helical CT scanning. World J Gastroenterol. 2007;13:1252-6. (Pubitemid 46592970)
19. Lesurtel M, Mullhaupt B, Pestalozzi BC, Pfammatter T, Clavien PA. Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. Am J Transplant. 2006;6:2644-50. (Pubitemid 44571684)
20. Tobe T, Uchino J, Endo Y, Oto M, Okamoto E, Kojiro M, et al. Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The Liver Cancer Study Group of Japan. Cancer. 1994;74:2772-80.
21. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, Ghobrial RM, et al. Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg. 2007;246:502-11.
22. Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation. 2006;81:1532-41. (Pubitemid 43890890)
23. Klintmalm GB. International registry of liver tumors in liver transplantation. A registry update on hepatocellular carcinoma (HCC). Zentralbl Chir. 2000;125:642-6.
24. Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl. 2002;8:736-48. (Pubitemid 35012281)
25. Zimmerman MA, Trotter JF, Wachs M, Bak T, Campsen J, Wright F et al. Predictors of long-term outcome following liver transplantation for hepatocellular carcinoma: a single-center experience. Transpl Int. 2007;747-753. (Pubitemid 47221058)
26. de Carlis L, Giacomoni A, Lauterio A, Slim A, Sammartino C, Pirotta V, et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int. 2003;16:115-22.
27. de Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Sammartino C, et al. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg. 2003;196:887-97. (Pubitemid 36676550)
28. Figueras J, Ibanez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, et al. Selection criteria for liver transplantation in earlystage hepatocellular carcinoma with cirrhosis: results of a multicenter study. Liver Transpl. 2001;7:877-83. (Pubitemid 33040462)
29. Margarit C, Charco R, Hidalgo E, Allende H, Castells L, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg. 2002;26:257-63. (Pubitemid 36920440)
30. Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg. 2001;136:25-30.
31. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, et al. Small hepatocellular carcinoma in Child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl. 2003;9:513-20. (Pubitemid 36621722)
32. Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg. 2000;190:580-7. (Pubitemid 30230706)
33. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, et al. Liver transplantation for hepatocellular carcinoma: a proposal of a prognostic scoring system. J Am Coll Surg. 2000;191:389-94.
34. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080-6.
35. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907-17. (Pubitemid 37518510)
36. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer. 2000;88:538-43.
37. Salizzoni M, Romagnoli R, Lupo F, David E, Mirabella S, Cerutti E, et al. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation. Transplantation. 2003;76:844-8. (Pubitemid 37140230)
38. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl. 2004;10:36-41. (Pubitemid 38885890)
39. Ravaioli M, Grazi GL, Ballardini G, Cavrini G, Ercolani G, Cescon M, et al. Liver transplantation with the Meld system: a prospective study from a single European center. Am J Transplant. 2006;6:1572-7. (Pubitemid 43945796)
40. Khettry U, Azabdaftari G, Simpson MA, Pomfret EA, Pomposelli JJ, Lewis WD, et al. Impact of model for end-stage liver disease (MELD) scoring system on pathological findings at and after liver transplantation. Liver Transpl. 2006;12:958-65. (Pubitemid 43960372)